This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chad David Brown, Pharmaceutical Formulation Inventor.
Introduction
Chad David Brown is an inventor associated with Pittstown, New Jersey, and Merck Sharp & Dohme LLC. His patent work concerns pharmaceutical formulations containing suvorexant, an orexin receptor antagonist.
Latest Patents
Brown is credited with 1 patent: “Solid Dosage Formulations of an Orexin Receptor Antagonist.” The invention describes a pharmaceutical composition comprising suvorexant, or a pharmaceutically acceptable salt of the compound, and a concentration-enhancing polymer. It may also include a pharmaceutically acceptable surfactant.
Career Highlights
Brown’s listed patent reflects work on solid dosage formulations designed to incorporate suvorexant and a concentration-enhancing polymer. The patent identifies Merck Sharp & Dohme LLC as his company affiliation.
Collaborations
Brown’s listed coworkers include Francis Flanagan and Paul A. Harmon.
Conclusion
Chad David Brown’s patent contribution focuses on a pharmaceutical formulation for suvorexant, developed in connection with Merck Sharp & Dohme LLC.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile